Press Release

KDA Group has signed an exclusive letter of intent to acquire tu ZRx prescriber technology asset for development and operation in the United States and Europe

Thetford Mines, Quebec – November 18, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the Corporation has signed an exclusive Letter of Intent (the “LOI”) with ZoomMed Medical Inc. (“ZoomMed Medical”) for the acquisition of the ZRx Prescriber technology asset consisting of its platform and source codes (the “ZRx Prescriber Asset”). KDA aims to develop and use the ZRx Prescriber Asset in the United States and Europe.

KDA Group amends the expiry date of 1,890,333 warrants

Thetford Mines, Quebec – October 16, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that it proposed to amend the expiry date of 13,890,333 warrants to purchase 13,890,333 Class A Shares of KDA (the “Common shares”) at a price of $0.20 per Common share from November 7, 2020 to November 7, 2021 as permitted under the TSX Venture Exchange (“TSXV”) Policy.

KDA Group amends the expiry date of 9,860,000 warrants

Thetford Mines, Quebec – September 29, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that it proposed to amend the expiry date of 9,860,000 warrants to purchase 9,860,000 Class A shares of KDA (the “Common shares”) at a price of $0.40 per Common share from October 22, 2020 to October 22, 2022 as permitted under the TSX Venture Exchange (“TSXV”) Policy.

KDA Group and ID Solution sign a letter of intent for distribution of screening technology products

Thetford Mines, Quebec – July 15, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the Corporation has signed an exclusive letter of intent (the “Letter of Intent”) with ID Solution Inc. (“ID Solution”) for the sale and distribution of screening technology products (the “Products”) in the field of medical safety and security for pharmacies, laboratories, nursing homes, hospitals, clinics and any other building for the Canadian market in the healthcare sector. These Products are of particular interest during these times of pandemic associated to COVID-19.

Groupe KDA © 2019  |  Tous droits réservés